Poland
# |
Name |
Price to Sales Ratio (P/S) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
1,481,732.57 |
Jan. 14, 2025 | USD 2.23 | 1.07% |
|
Poland |
|
2 |
91,280.05 |
Jan. 14, 2025 | USD 1.74 | 1.31% |
|
Poland |
|
3 |
43,209.58 |
Jan. 14, 2025 | USD 0.79 | 1.05% |
|
Poland |
|
4 |
835.38 |
Jan. 14, 2025 | USD 40.10 | -0.57% |
|
Poland |
|
5 |
547.05 |
Jan. 14, 2025 | USD 3.73 | -0.03% |
|
Poland |
|
6 |
209.87 |
Jan. 14, 2025 | USD 1.85 | -0.17% |
|
Poland |
|
7 |
122.11 |
Jan. 14, 2025 | USD 9.29 | -3.28% |
|
Poland |
|
8 |
15.14 |
Jan. 14, 2025 | USD 7.78 | -9.75% |
|
Poland |
|
9 |
14.69 |
Jan. 14, 2025 | USD 10.54 | 0.97% |
|
Poland |
|
10 |
10.04 |
Jan. 14, 2025 | USD 0.71 | 0.06% |
|
Poland |
|
11 |
7.87 |
Jan. 14, 2025 | USD 6.09 | -0.44% |
|
Poland |
|
12 |
4.98 |
Jan. 14, 2025 | USD 1.05 | -1.52% |
|
Poland |
|
13 |
4.50 |
Jan. 14, 2025 | USD 1.01 | 1.23% |
|
Poland |
|
14 |
2.68 |
Jan. 14, 2025 | USD 50.91 | 0.74% |
|
Poland |
|
15 |
2.32 |
Jan. 14, 2025 | USD 11.11 | -3.75% |
|
Poland |
|
16 |
1.43 |
Jan. 14, 2025 | USD 0.77 | 0.43% |
|
Poland |
|
17 |
1.00 |
Jan. 14, 2025 | USD 12.79 | 0.55% |
|
Poland |
|
18 |
0.98 |
Jan. 14, 2025 | USD 2.34 | 1.69% |
|
Poland |
|
19 |
0.98 |
Jan. 14, 2025 | USD 2.77 | 1.63% |
|
Poland |
|
20 |
0.89 |
Jan. 14, 2025 | USD 4.92 | 2.76% |
|
Poland |
|
21 |
0.31 |
Jan. 14, 2025 | USD 204.85 | 1.34% |
|
Poland |
The Pharmaceuticals company in Poland with the highest Price to Sales Ratio (P/S) is Molecure S.A. (Warsaw Stock Exchange: MOC.WA) at 1,481,732.57.
The Pharmaceuticals company in Poland with the lowest Price to Sales Ratio (P/S) is NEUCA S.A. (Warsaw Stock Exchange: NEU.WA) at 0.31.
The top 10 Pharmaceuticals companies in Poland by Price to Sales Ratio (P/S) are Molecure S.A., Genomtec S.A., NanoGroup S.A., Scope Fluidics S.A., Pure Biologics Spólka Akcyjna, Medinice S.A., Poltreg S.A., Ryvu Therapeutics S.A., Captor Therapeutics Spolka Akcyjna and M.W. Trade SA.
The bottom 10 Pharmaceuticals companies in Poland by Price to Sales Ratio (P/S) are NEUCA S.A., Centrum Medyczne ENEL-MED S.A., BioMaxima S.A., Mabion S.A., Mercator Medical S.A., BIOTON S.A., Selvita S.A., Synektik Spólka Akcyjna, Pharmena S.A. and Synthaverse S.A..